Showing results (991-1000 of 1,808) with videos related to

Sort By:
Pageof 181
Acta Oncologica (Stockholm, Sweden)|October 21, 2014
Cyclin E1 is a strong prognostic marker for death from lymph node negative breast cancer. A population-based case-control studyClaudia Lundgren, Cecilia Ahlin, Lars Holmberg, et al.
BMC Cancer|December 12, 2022
Markers associated with genomic instability, immunogenicity and immune therapy responsiveness in Metaplastic carcinoma of the breast: Expression of γH2AX, pRPA2, P53, PD-L1 and tumor infiltrating lymphocytes in 76 casesS Voutilainen, P Heikkilä, J Bartkova, et al.
International Journal of Radiation Oncology, Biology, Physics|January 5, 2002
Pulmonary toxicity after radiotherapy in primary breast cancer patients: results from a randomized chemotherapy studyMicaela Hernberg, Pekka Virkkunen, Paula Maasilta, et al.
The British Journal of Dermatology|June 20, 2002
Quality of life in 6497 Nordic patients with psoriasisR Zachariae, H Zachariae, K Blomqvist, et al.
European Journal of Oral Sciences|June 15, 2005
How do children with attention deficit hyperactivity disorder interact in a clinical dental examination? A video analysisMy Blomqvist, Mikael Augustsson, Christine Bertlin, et al.
International Journal of Dermatology|May 5, 2005
Lifestyle of Nordic people with psoriasisSteingrimur Davidsson, Kirsti Blomqvist, Lars Molin, et al.
SLAS Discovery : Advancing Life Sciences R & D|April 25, 2018
Comparing Flow Cytometry QBeads PlexScreen Assays with Other Immunoassays for Determining Multiple AnalytesMei Ding, Anders Cavallin, Nils-Olov Hermansson, et al.
European Addiction Research|February 2, 2011
Perceptions of addictions as societal problems in Canada, sweden, Finland and st. Petersburg, RussiaKari Holma, Anja Koski-Jännes, Kirsimarja Raitasalo, et al.
Nanotechnology|July 27, 2011
Theoretical study of C60 as catalyst for dehydrogenation in LiBH4Ralph H Scheicher, Sa Li, C Moyses Araujo, et al.
Histopathology|August 23, 2007
Ki67 and cyclin A as prognostic factors in early breast cancer. What are the optimal cut-off values?C Ahlin, K Aaltonen, R-M Amini, et al.
Pageof 181